Atlas Trials

A Bioequivalence Study of Famitinib Malate on Healthy Chinese Volunteers

Clinical trial NCT04400123 · COMPLETED

Trial details

NCT number
NCT04400123
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Adult Subjects
Start date
2020-05-27
Primary completion
2020-07-18
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.